Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PR104 in Relapsed/Refractory Acute Leukemia
NCT01037556Phase 2Unknown
- Sponsor
- Proacta Inc.
- Start
- Jan 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PR-104 in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Proacta Inc.. Status: unknown.
02
Drugs
PR-104
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01037556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037556.